4//SEC Filing
Sabag Mark 4
Accession 0000950170-25-033597
CIK 0000818686other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:16 PM ET
Size
7.4 KB
Accession
0000950170-25-033597
Insider Transaction Report
Form 4
Sabag Mark
See "Remarks"
Transactions
- Exercise/Conversion
Ordinary Shares
2025-03-03+24,900→ 229,864 total - Exercise/Conversion
Restricted Share Units
2025-03-03−24,900→ 49,801 total→ Ordinary Shares (24,900 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on March 3, 2023, with 24,900 vested on each of March 3, 2024 and March 3, 2025, 24,900 vesting on March 3, 2026, and 24,901 vesting on March 3, 2027.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001721442
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:16 PM ET
- Size
- 7.4 KB